Garen G Bohlin is of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 45,140 shares of KPTI, which is worth approximately $34,306. The most recent transaction as insider was on Sep 12, 2023, when has been sold 41,140 shares (Common Stock) at a price of $1.22 per share, resulting in proceeds of $50,190. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 45.1K
0% 3M change
0% 12M change
Total Value Held $34,306

GAREN G BOHLIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 12 2023
BUY
Open market or private purchase
$50,190 $1.22 p/Share
41,140 Added 47.68%
45,140 Common Stock
May 06 2021
BUY
Open market or private purchase
$31,280 $7.82 p/Share
4,000 Added 50.0%
4,000 Common Stock

Also insider at

COLL
COLLEGIUM PHARMACEUTICAL, INC Healthcare
GGB

Garen G Bohlin

Stoughton, MA

Track Institutional and Insider Activities on KPTI

Follow Karyopharm Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KPTI shares.

Notify only if

Insider Trading

Get notified when an Karyopharm Therapeutics Inc. insider buys or sells KPTI shares.

Notify only if

News

Receive news related to Karyopharm Therapeutics Inc.

Track Activities on KPTI